Carregant...

How we treat cytomegalovirus in hematopoietic cell transplant recipients

Cytomegalovirus (CMV) continues to cause major complications after hematopoietic cell transplantation (HCT). Over the past decade, most centers have adopted preemptive antiviral treatment or prophylaxis strategies to prevent CMV disease. Both strategies are effective but also have shortcomings with...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Boeckh, Michael, Ljungman, Per
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2009
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2700312/
https://ncbi.nlm.nih.gov/pubmed/19299333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-10-143560
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!